Austin, TX (November 19, 2014) - 

1st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that its RoHS compliant OEM-1000PI mass spectrometer has been certified by Underwriter Laboratories as a recognized component meeting IEC 61010-1:2010 (3rd Edition) standards. Recognized component status enables our OEM customers to safely integrate the OEM-1000PI into their own products.

 

“We are committed to offering products and technologies that have compelling features and are also compliant with International Safety Standards." said Thomas B Pickens III, Chairman and CEO of 1st Detect. “Our OEM customers can now confidently integrate the OEM-1000PI product into safe solutions.”

 

“Our emphasis on delivering products that are standards based is clearly demonstrated by the RoHS and safety compliance certifications on the OEM-1000PI product.” added David Rafferty, President and CTO of 1st Detect.

 

1st Detect Corporation has developed an instrument that revolutionizes the chemical detection and analysis market by delivering lab performance mass spectrometry in a small, affordable and easily portable package. The 1st Detect mass spectrometer is capable of detecting a wide variety of chemicals including residues and vapors from explosives, chemical warfare agents, toxic chemicals, food and beverage contaminants, and pollutants. These abilities make it an ideal tool for a variety of applications in the research, security, industrial, process flow and healthcare markets.

 

About 1st Detect Corporation

1st Detect Corporation was formed by Astrotech Corporation (Nasdaq:ASTC) to develop and commercialize miniature mass spectrometry technology first developed under an agreement with NASA for use on the International Space Station. 1st Detect offers a breakthrough miniaturized mass spectrometer that fills an unmet need by being highly accurate, rapid, lightweight, and cost-effective. For more information on 1st Detect Corporation, please visit www.1stDetect.com.

 

About Astrotech Corporation

Astrotech is a leader in identifying and commercializing space technology for terrestrial use. 1st Detect Corporation is developing what we believe is a breakthrough miniaturized mass spectrometer, the MMS-1000™, while Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development. Astral Images provides an advanced film scanning and digital defect removal solution. All are wholly owned subsidiaries of the parent.

 

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

 

FOR MORE INFORMATION: 

 

Joshua Elbaum
VP, Marketing
+1 (512) 485-9530